Alibaba Leads ~USD88m Series D for China’s Creative Biosciences

Alibaba led a CNY560m (~USD88m) Series D for Creative Biosciences, a China-based early-stage cancer screening solutions company, with participation from Huaxing Growth Capital, Co-Stone Asset Management, ABC International and Henglu Asset Management, and follow-on from IDG Capital. Read more… Read More

XPeng, IDG and 5Y Lead USD500m Series A for China’s HT Aero

XPeng, IDG Capital and 5Y Capital led a USD500m Series A for HT Aero, a China-based urban air mobility company backed by XPeng, at a reported USD1b valuation, with participation from Sequoia Capital China, Eastern Bell Capital, GGV Capital, GL Ventures and Yunfeng Capital. Read more… Read More



(default archive template)